Theriva Biologics, Inc.

NYSE American: TOVX
Share price (12/20/24): $1.14
Market cap (12/20/24): $3.172 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 5 pages Amendment to Share Purchase Agreement

from 8-K 89 pages Share Purchase Agreement by and Among Synthetic Biologics, Inc., Vcn Biosciences, S.L. and the Shareholders of Vcn Biosciences, S.L. Dated as of December 14, 2021

from SC 13D/A ~1 page Joint Filing Agreement

from 8-K 1 page Plan of reorganization, merger, acquisition or similar

from 8-K 1 page Plan of reorganization, merger, acquisition or similar

from 8-K ~20 pages Form of Sublicense and Development Agreement

from 8-K 1 page Press Release of the Company Dated April 16, 1998